tiprankstipranks
Advertisement
Advertisement

IVBXF Stock Latest News

Innovent Biologics Grants New Share Options and Restricted Shares Under 2024 Scheme
Company AnnouncementsInnovent Biologics Grants New Share Options and Restricted Shares Under 2024 Scheme
14d ago
Innovent Biologics Hits Record Revenue and Turns Profitable in 2025
PremiumCompany Announcements
Innovent Biologics Hits Record Revenue and Turns Profitable in 2025
18d ago
Innovent Confirms Lilly Collaboration Effective, Denies Acquisition Rumors
PremiumCompany Announcements
Innovent Confirms Lilly Collaboration Effective, Denies Acquisition Rumors
20d ago
Innovent Biologics Sets March Board Meeting to Approve 2025 Results and Mull Dividend
PremiumCompany Announcements
Innovent Biologics Sets March Board Meeting to Approve 2025 Results and Mull Dividend
1M ago
Pfizer’s Weight-Loss Drug Approved in China — Up Against Generic Rivals
PremiumMarket News
Pfizer’s Weight-Loss Drug Approved in China — Up Against Generic Rivals
1M ago
LLY
NVO
Innovent Biologics receives approval by NMPA in China for CLL/SLL
PremiumThe FlyInnovent Biologics receives approval by NMPA in China for CLL/SLL
1M ago
Innovent Wins China Approval for New Jaypirca Leukemia Indication
Premium
Company Announcements
Innovent Wins China Approval for New Jaypirca Leukemia Indication
2M ago
Why Did Innovent Biologics Shares Surge?
Premium
Market News
Why Did Innovent Biologics Shares Surge?
2M ago
LLY
Innovent Biologics announces collaboration with Lilly
PremiumThe Fly
Innovent Biologics announces collaboration with Lilly
2M ago
Innovent Strikes US$8.85 Billion Global Oncology and Immunology Pact With Eli Lilly
PremiumCompany Announcements
Innovent Strikes US$8.85 Billion Global Oncology and Immunology Pact With Eli Lilly
2M ago
Innovent Surpasses RMB10 Billion in 2025 Product Revenue on Oncology and Chronic Disease Momentum
PremiumCompany Announcements
Innovent Surpasses RMB10 Billion in 2025 Product Revenue on Oncology and Chronic Disease Momentum
2M ago
Innovent Wins Landmark China Approval for First Domestic CTLA-4 Neoadjuvant Colon Cancer Therapy
PremiumCompany Announcements
Innovent Wins Landmark China Approval for First Domestic CTLA-4 Neoadjuvant Colon Cancer Therapy
4M ago
Innovent Biologics announces initial data of IBI3003
PremiumThe FlyInnovent Biologics announces initial data of IBI3003
4M ago
Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
Premium
Company Announcements
Innovent Biologics’ Seven Drugs Added to China’s National Reimbursement List
4M ago
Innovent Biologics Grants Share Options to Boost Employee Engagement
Premium
Company Announcements
Innovent Biologics Grants Share Options to Boost Employee Engagement
4M ago
Innovent Biologics Closes Strategic Partnership with Takeda
PremiumCompany Announcements
Innovent Biologics Closes Strategic Partnership with Takeda
4M ago
Innovent Biologics enters HSI, two other major indices
PremiumThe Fly
Innovent Biologics enters HSI, two other major indices
4M ago
Innovent Biologics’ PECONDLE® Approved for Psoriasis Treatment in China
PremiumCompany Announcements
Innovent Biologics’ PECONDLE® Approved for Psoriasis Treatment in China
5M ago
Innovent’s Mazdutide 9mg Application Accepted by China’s NMPA
PremiumCompany Announcements
Innovent’s Mazdutide 9mg Application Accepted by China’s NMPA
5M ago
Innovent Biologics, Sanegene Bio announces results on IBI3016
PremiumThe FlyInnovent Biologics, Sanegene Bio announces results on IBI3016
5M ago
Innovent Biologics Achieves 40% Revenue Growth in Q3 2025
Premium
Company Announcements
Innovent Biologics Achieves 40% Revenue Growth in Q3 2025
6M ago
Innovent Biologics and Takeda Partnership Fuels Global Expansion and Strengthens Buy Rating
Premium
Ratings
Innovent Biologics and Takeda Partnership Fuels Global Expansion and Strengthens Buy Rating
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >